GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: results of a multicenter study

Bone Marrow Transplant. 2016 Nov;51(11):1524-1526. doi: 10.1038/bmt.2016.163. Epub 2016 Jun 13.

Authors

R Parody¹, L López-Corral², O Lopez-Godino², C Martinez³, R Martino⁴, C Solano⁵, P Barba⁶, D Caballero², I García-Cadenas⁴, J L Piñana⁵, F J Marquez-Malaver¹, L Vazquez², A Esquirol⁴, J C H Boluda⁵, F Sanchez-Guijo², J A Pérez-Simon¹

Affiliations

¹ Hospital Universitario Virgen del Rocío/Virgen Macarena, Instituto de Biomedicina de Sevilla (IBIS), Universidad de Sevilla, Sevilla, Spain.
² Hospital Universitario de Salamanca, Salamanca, Spain.
³ Hospital Clinic de Barcelona, Barcelona, Spain.
⁴ Hospital de la Santa Creu i Sant Pau, IIB Sant Pau and Jose Carreras Institute, Universidad Autónoma de Barcelona, Barcelona, Spain.
⁵ Hospital Clínico de Valencia, Valencia, Spain.
⁶ Hospital Vall d'Hebron, Barcelona, Spain.

PMID: 27295268
DOI: 10.1038/bmt.2016.163

No abstract available

Publication types

Letter
Multicenter Study
Research Support, N.I.H., Extramural

MeSH terms

Adolescent
Adult
Aged
Female
Graft vs Host Disease / drug therapy
Graft vs Host Disease / mortality
Graft vs Host Disease / prevention & control*
Hematologic Neoplasms / therapy
Hematopoietic Stem Cell Transplantation / adverse effects*
Hematopoietic Stem Cell Transplantation / methods
Hematopoietic Stem Cell Transplantation / mortality
Humans
Immunosuppressive Agents / therapeutic use*
Male
Middle Aged
Sirolimus / therapeutic use
Survival Analysis
Tacrolimus / therapeutic use
Transplantation Conditioning / methods*
Transplantation, Homologous

Substances

Immunosuppressive Agents
Sirolimus
Tacrolimus